U.S., Aug. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07770685) titled 'A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve Damage' on Aug. 14.
Brief Summary: Open-angle glaucoma is the most common type of glaucoma, a disease that damages the nerves in the eye and can lead to vision loss. Current treatments include eye drops, laser treatment, and surgery that help lower eye pressure. However, they do not work for everyone, and the disease may continue to worsen over time. Researchers are looking for better ways to treat open-angle glaucoma.
This is an early development study of ASP2767 in people with open-angle glaucoma. In this study, ASP2767 will be given...